Goldman Sachs invests in Aragen Life Sciences for significant minority stake
Goldman Sachs invests in Aragen Life Sciences for significant minority stake Goldman Sachs Goldman Sachs on Wednesday said it has made an investment in Aragen Life Sciences for a significant minority stake in the contract research organization. It, however, did not disclose the value of the investment. Goldman Sachss alternative investing arm Goldman Sachs Asset Management picked up shares in the company, which was earlier known as GVK Biosciences, from Chryscapital and other investors, as per ...
Michael Bruun Manni Kantipudi Biocon Biologics Nova Medical Centers Aragen Life Sciences Goldman Sachs
Source: freepressjournal.in